Polyrizon Secures GMP Manufacturing for PL-14 Allergy Blocker

Ticker: PLRZ · Form: 6-K · Filed: Dec 2, 2024 · CIK: 1893645

Polyrizon Ltd. 6-K Filing Summary
FieldDetail
CompanyPolyrizon Ltd. (PLRZ)
Form Type6-K
Filed DateDec 2, 2024
Risk Levelmedium
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: manufacturing, clinical-trial, pharmaceutical

TL;DR

Polyrizon inks GMP deal for PL-14 allergy blocker, prepping for 2025 trials.

AI Summary

Polyrizon Ltd. announced on December 2, 2024, that it has entered into a GMP manufacturing agreement with an unnamed partner for the CTM supply of its PL-14 Allergy Blocker. This agreement is in preparation for a planned clinical trial in 2025. The company is a pharmaceutical preparations company based in Israel.

Why It Matters

This agreement is a crucial step for Polyrizon as it enables the production of their PL-14 allergy blocker under strict quality standards, paving the way for their upcoming clinical trials.

Risk Assessment

Risk Level: medium — The filing is a routine announcement of a manufacturing agreement, but the success of the PL-14 product and the clinical trial are still uncertain.

Key Players & Entities

  • Polyrizon Ltd. (company) — Registrant
  • PL-14 Allergy Blocker (product) — Product being manufactured
  • December 2, 2024 (date) — Date of press release
  • 2025 (date) — Year of planned clinical trial

FAQ

What is the name of the partner Polyrizon Ltd. entered into the GMP manufacturing agreement with?

The filing does not disclose the name of the partner with whom Polyrizon Ltd. entered into the GMP manufacturing agreement.

What is the specific timeline for the planned 2025 clinical trial?

The filing states the clinical trial is 'planned for 2025' but does not provide a more specific timeline within that year.

What is the primary indication for the PL-14 Allergy Blocker?

The filing identifies PL-14 as an 'Allergy Blocker', indicating its intended use is for treating allergies.

What does GMP stand for in the context of the manufacturing agreement?

GMP stands for Good Manufacturing Practice, which are quality standards for manufacturing.

What is Polyrizon Ltd.'s SIC code?

Polyrizon Ltd.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 204 words · 1 min read · ~1 pages · Grade level 13.8 · Accepted 2024-12-02 16:01:10

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Polyrizon Ltd. Date: December 2, 2024 By: /s/ Tomer Izraeli Name: Tomer Izraeli Title: Chief Executive Officer 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.